What are the first‑line treatment recommendations for anxiety?

First-Line Recommendations for Anxiety

For adults with anxiety disorders, start with either SSRIs (selective serotonin reuptake inhibitors) or cognitive behavioral therapy (CBT) as first-line treatment, with SSRIs being the preferred pharmacological option and CBT the preferred psychotherapy. 1, 2

Pharmacological Treatment

First-Line Medications

SSRIs are the primary first-line pharmacological treatment for anxiety disorders, including panic disorder, generalized anxiety disorder (GAD), and social anxiety disorder 1, 2, 3. The most commonly recommended SSRIs include:

• Escitalopram
• Sertraline
• Paroxetine
• Fluvoxamine

SNRIs (serotonin-norepinephrine reuptake inhibitors), particularly venlafaxine, are also first-line options 1, 2, 3. These medications show comparable efficacy to SSRIs and can be used as an alternative first-line choice.

Treatment Duration and Monitoring

• Continue medications for 6-12 months after achieving remission 3, 4
• If no response after 8 weeks of adequate dosing, switch to an alternative SSRI/SNRI or add psychotherapy 5
• Monthly monitoring is recommended until symptoms subside 5

Important Caveats

Benzodiazepines are NOT recommended as first-line treatment despite their rapid anxiolytic effects 5, 6, 4. They carry significant risks including:

• Addiction potential with long-term use
• Cognitive impairment
• Increased fall risk, especially in older adults

If benzodiazepines are used, they should be time-limited only while awaiting SSRI/SNRI onset of action 6.

Psychological Treatment

First-Line Psychotherapy

Cognitive behavioral therapy (CBT) is the first-line psychotherapy for all anxiety disorders 1, 7, 2, 3. Specific evidence-based CBT models include:

• For social anxiety disorder: Clark and Wells model or Heimberg model delivered through individual sessions (14 sessions over ~4 months, 60-90 minutes each) 1
• For panic disorder and GAD: Standard CBT protocols
• For specific phobias: Exposure therapy

CBT should be delivered by a skilled therapist following structured, manualized protocols 1. Individual therapy is prioritized over group therapy due to superior clinical and cost-effectiveness 1.

Alternative Delivery Methods

If face-to-face CBT is unavailable or declined by the patient:

• Self-help with support based on CBT principles is recommended as a second-line option 1
• Brief CBT delivered by embedded behavioral health clinicians in primary care settings is effective 6
• Internet-based CBT interventions can be considered 3

Treatment Selection Algorithm

For Mild to Moderate Anxiety

1. Start with CBT as monotherapy 7, 6
2. If CBT unavailable or patient preference, initiate SSRI monotherapy
3. Reassess at 8 weeks

For Moderate to Severe Anxiety

1. Consider combination treatment (CBT + SSRI) from the outset, as this may be more effective than either alone 7
2. If monotherapy preferred, start with SSRI given severity
3. Add CBT if partial response to medication alone

For Subthreshold Symptoms

• Begin with self-help and behavioral interventions before escalating to formal CBT or medications 6

Treatment-Resistant Cases

If first-line treatments fail after adequate trial (8-12 weeks at therapeutic doses):

1. Switch to alternative SSRI or SNRI 3
2. Add the other modality (if on medication alone, add CBT; if CBT alone, add medication) 5
3. Consider second-line options: pregabalin (for GAD), tricyclic antidepressants, or buspirone 2, 4

Strength of Evidence Considerations

The evidence quality for these recommendations is generally low to moderate (GRADE 2C for SSRIs/SNRIs) 1, reflecting:

• Heterogeneity in study populations
• Variable outcome measures across trials
• Limited long-term follow-up data
• Underrepresentation of diverse populations

However, the consistency of recommendations across multiple international guidelines (Japanese, German, WFSBP, AACAP) 1, 7, 2, 3 provides strong consensus support for SSRIs/SNRIs and CBT as first-line treatments.

Special Populations

For children and adolescents: CBT is preferred as first-line treatment, with SSRIs reserved for moderate-to-severe presentations or when quality CBT is unavailable 7.

Collaborative Care Management involving primary care clinicians, consulting psychiatrists, and care managers improves anxiety outcomes compared to usual care 6.